Evidence map›Paper›PMID 25707398›Full record

ArticleMolecular psychiatry2016

Disruptive de novo mutations of DYRK1A lead to a syndromic form of autism and ID.

B W M van Bon, B P Coe, R Bernier, C Green, J Gerdts, K Witherspoon, T Kleefstra, M H Willemsen, R Kumar, P Bosco and 12 more

Open access · greenAbstract read
In one paragraph

Article in Molecular psychiatry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 111 papers.

0numbers the graph read from it
0cells of the map it votes in
111citing papers in PubMed
29.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

111 citing papers in PubMed, 206 citations in OpenAlex.

  1. Article
  2. Article
  3. Epigenetic treatment of synaptic and behavioral deficits in Dyrk1a-mutant mice.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  4. Up-regulation of Minibrain/DYRK1A contributes to macrocephaly and brain overgrowth in aProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Visual and auditory attention in individuals with DYRK1A and SCN2A disruptive variants.Autism research : official journal of the International Society for Autism Research · 2025
    Article
  10. Article
  11. DYRK1A roles in human neural progenitors.Frontiers in neuroscience · 2025
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

51 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 10 institutions in 5 countries.

B W M van BonDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
B P CoeDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA.
R BernierDepartment of Psychiatry, University of Washington, Seattle, WA, USA.
C GreenFlorey Institute, University of Melbourne, Austin Health and Royal Children's Hospital, Melbourne, Victoria, Australia.
J GerdtsDepartment of Psychiatry, University of Washington, Seattle, WA, USA.
K WitherspoonDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA.
T KleefstraDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
M H WillemsenDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
R KumarSchool of Paediatrics and Reproductive Health, University of Adelaide, Adelaide, South Australia, Australia.
P BoscoI.R.C.C.S. Associazione Oasi Maria Santissima, Troina, Italy.
M FicheraI.R.C.C.S. Associazione Oasi Maria Santissima, Troina, Italy.
D LiRepresenting the Autism Phenome Project, MIND Institute, University of California-Davis, Sacramento, CA, USA.
D AmaralRepresenting the Autism Phenome Project, MIND Institute, University of California-Davis, Sacramento, CA, USA.
F CristofoliCenter for Human Genetics, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
H PeetersCenter for Human Genetics, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
E HaanSchool of Paediatrics and Reproductive Health, University of Adelaide, Adelaide, South Australia, Australia.
C RomanoI.R.C.C.S. Associazione Oasi Maria Santissima, Troina, Italy.
H C MeffordDepartment of Psychiatry, University of Washington, Seattle, WA, USA.
I SchefferFlorey Institute, University of Melbourne, Austin Health and Royal Children's Hospital, Melbourne, Victoria, Australia.
J GeczSchool of Paediatrics and Reproductive Health, University of Adelaide, Adelaide, South Australia, Australia.ORCID http://orcid.org/0000-0002-7884-6861
B B A de VriesDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
E E EichlerDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA.
University of Washington · USRadboud University Nijmegen · NLAutism Research Institute · USI.R.C.C.S. Oasi Maria SS · ITKU Leuven · BERoyal Children's Hospital · AUSouth Australia Pathology · AUHoward Hughes Medical Institute · USThe University of Adelaide · AUUniversity of Catania · IT

Funding

Sporadic Mutations and Autism Spectrum DisordersR01MH101221 · NIMH · UNIVERSITY OF WASHINGTON · PI EICHLER, EVAN · 2013 to 2025
$9.2M
Intellectual and Developmental Disabilities Research CenterU54HD083091 · NICHD · UNIVERSITY OF WASHINGTON · PI GURALNICK, MICHAEL J · 2014 to 2019
$7.9M
A Genomic Approach to EpilepsyR01NS069605 · NINDS · UNIVERSITY OF WASHINGTON · PI MEFFORD, HEATHER C. · 2010 to 2019
$4.9M
Phenotypic Characterization of Gene Disrupting Mutations in ASDR01MH100047 · NIMH · UNIVERSITY OF WASHINGTON · PI BERNIER, RAPHAEL A · 2014 to 2018
$2.1M
Howard Hughes Medical InstituteNICHD NIH HHS U54 HD083091NIMH NIH HHS R01 MH100047NIMH NIH HHS R01 MH101221NIMH NIH HHS R01MH101221NINDS NIH HHS R01 NS069605
6 · The paper itself

Abstract

Dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 1 A (DYRK1A) maps to the Down syndrome critical region; copy number increase of this gene is thought to have a major role in the neurocognitive deficits associated with Trisomy 21. Truncation of DYRK1A in patients with developmental delay (DD) and autism spectrum disorder (ASD) suggests a different pathology associated with loss-of-function mutations. To understand the phenotypic spectrum associated with DYRK1A mutations, we resequenced the gene in 7162 ASD/DD patients (2446 previously reported) and 2169 unaffected siblings and performed a detailed phenotypic assessment on nine patients. Comparison of our data and published cases with 8696 controls identified a significant enrichment of DYRK1A truncating mutations (P=0.00851) and an excess of de novo mutations (P=2.53 × 10(-10)) among ASD/intellectual disability (ID) patients. Phenotypic comparison of all novel (n=5) and recontacted (n=3) cases with previous case reports, including larger CNV and translocation events (n=7), identified a syndromal disorder among the 15 patients. It was characterized by ID, ASD, microcephaly, intrauterine growth retardation, febrile seizures in infancy, impaired speech, stereotypic behavior, hypertonia and a specific facial gestalt. We conclude that mutations in DYRK1A define a syndromic form of ASD and ID with neurodevelopmental defects consistent with murine and Drosophila knockout models.

Indexed as

MutationPhenotypeAdolescentAdultAutistic DisorderChildChild, PreschoolCohort StudiesDyrk KinasesFemaleFetal Growth RetardationHumansIntellectual DisabilityMaleMicrocephalyMiddle AgedDyrk KinasesProtein Serine-Threonine KinasesProtein-Tyrosine Kinases

Identifiers

PMID25707398
PMCPMC4547916
OpenAlexW1978701742

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.